MoonLake Immunotherapeutics (MLTXN.MX) Q2 2025 Earnings

12MayConfirmed
Q4 2024
Q1 2025
Q2 2025
-14.78
-12.73
-10.67
-8.62

Details

Expected EPS
-14.782456296
Actual EPS
-12.352535999999999
Surprise EPS
2.43
Surprise Percent
+16.44%

Description

MoonLake Immunotherapeutics (MLTXN.MX) has reported earnings of -12.352535999999999 per share for Q2 2025.

0 Comments

Share your thoughts